FGF13 Regulates Myocardial Ischemia-Reperfusion Injury via PGRN Glycosylation
Circulation Research · 13.11.2026
DOI: 10.1161/circresaha.126.329008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, online erschienen am 13.11.2026. Verfasst von Yiming Dong und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Postdoctoral Research Station of Basic Medicine, Hebei Medical University, Shijiazhuang, China (Y.D., Y.W., S.L., Y.Y.). Die Arbeit nennt 61 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Macrophage polarization and complement activation play a pivotal role in the pathogenesis of myocardial ischemia-reperfusion (I/R) injury. FGF13 (fibroblast growth factor 13) is a critical regulator of cardiac homeostasis. However, the role and mechanism of FGF13 in myocardial I/R injury remain unclear. METHODS: FGF13 expression was detected in cardiomyocytes after hypoxia/reoxygenation and in hearts subjected to myocardial I/R. Cardiomyocyte-specific FGF13 knockout and adeno-associated virus serotype 9–mediated overexpression mice were generated. Transcriptomic and proteomic analyses identified key downstream mechanisms. Immunoprecipitation–mass spectrometry, co-immunoprecipitation, and glycoproteomics identified PGRN (progranulin) as an FGF13-interacting protein and mapped its glycosylation site. Mechanistic studies were performed using Transwell cocultures of neonatal mouse cardiomyocytes and bone marrow–derived macrophages, together with molecular and biochemical approaches. Virtual screening and molecular dynamics simulations identified a small-molecule FGF13 inhibitor. RESULTS: FGF13 was upregulated in cardiomyocytes after myocardial I/R. Cardiomyocyte-specific FGF13 knockout alleviated, whereas overexpression exacerbated, cardiac dysfunction and myocardial injury after I/R. Mechanistically, FGF13, through its asparagine 121 residue, competitively occupied the asparagine 263 glycosylation site of PGRN, sterically preventing STT3A (STT3 oligosaccharyltransferase complex catalytic subunit A)–mediated glycosylation of asparagine 263 and suppressing PGRN secretion. FGF13 depletion restored PGRN glycosylation and secretion, which activated macrophage TNFR2/PI3K/AKT (tumor necrosis factor receptor 2/phosphoinositide 3-kinase/protein kinase B) signaling in a paracrine manner, promoted M2 polarization while suppressing M1 polarization, and inhibited complement activation and inflammation. The small-molecule FGF13 inhibitor CWD8 (1-[2-amino-2-methylpropyl]-5,5-dimethylpiperidin-3-ol) also attenuated myocardial I/R injury. CONCLUSIONS: Our findings highlight the critical role of FGF13 in myocardial I/R injury and reveal a competitive mechanism by which FGF13 hinders STT3A-mediated PGRN glycosylation. We identify the PGRN glycosylation–PI3K/AKT axis as the key downstream pathway mediating FGF13-regulated macrophage polarization and complement activation, suggesting that small-molecule FGF13 inhibitors may represent a promising therapeutic strategy for myocardial I/R injury.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Postdoctoral Research Station of Basic Medicine, Hebei Medical University, Shijiazhuang, China (Y.D., Y.W., S.L., Y.Y.).
- Department of Vascular Surgery (H.W., X.G.), The Second Hospital of Hebei Medical University, Shijiazhuang, China.
- Affiliated Hospital of Hebei University, Clinical Medical College, Hebei University, Baoding, China (J.S., Yiyi Zhang, C.W.).
- Department of Cardiology (Yawei Liu, W.Y., B.G.), The Second Hospital of Hebei Medical University, Shijiazhuang, China.
- College of Pharmaceutical Sciences, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis, Ministry of Education, Hebei University, Baoding, China (Yongfang Zhang, L.L., C.W.).
- College of Traditional Chinese Medicine, Hebei University, Baoding, China (H.X., J.T.).
ORCID-Profile: Yiming Dong, Jianhong Shi, Hongkun Xue, Jiaqi Tan, Zhiming Zhao, Chuan Wang
Zitieren
APA
Dong, Y., Wang, H., Wang, Y., Lv, S., Shi, J., Liu, Y., Yan, Y., Zhang, Y., Xue, H., Tan, J., Liu, K., Zhao, Z., Yang, W., Zhang, Y., Liu, Y., Guo, B., Li, L., Yin, H., Gao, X., & Wang, C. (2026). FGF13 Regulates Myocardial Ischemia-Reperfusion Injury via PGRN Glycosylation. Circulation Research. https://doi.org/10.1161/circresaha.126.329008
Vancouver
Dong Y, Wang H, Wang Y, Lv S, Shi J, Liu Y, et al. FGF13 Regulates Myocardial Ischemia-Reperfusion Injury via PGRN Glycosylation. Circulation Research. 2026. doi:10.1161/circresaha.126.329008
BibTeX
@article{Dong2026,
author = {Dong, Yiming and Wang, Handong and Wang, Yidan and Lv, Simeng and Shi, Jianhong and Liu, Yawei and Yan, Yingke and Zhang, Yongfang and Xue, Hongkun and Tan, Jiaqi and Liu, Kun and Zhao, Zhiming and Yang, Wenhui and Zhang, Yiyi and Liu, Yibo and Guo, Bingyan and Li, Longfei and Yin, Hongshan and Gao, Xiang and Wang, Chuan},
title = {FGF13 Regulates Myocardial Ischemia-Reperfusion Injury via PGRN Glycosylation},
journal = {Circulation Research},
year = {2026},
doi = {10.1161/circresaha.126.329008}
}
EUVIMED